Please use this identifier to cite or link to this item: doi:10.22028/D291-43988
Volltext verfügbar? / Dokumentlieferung
Title: Effects of Catheter-Based Renal Denervation in Hypertension: A Systematic Review and Meta-Analysis
Author(s): Vukadinović, Davor
Lauder, Lucas
Kandzari, David E.
Bhatt, Deepak L.
Kirtane, Ajay J.
Edelman, Elazer R.
Schmieder, Roland E.
Azizi, Michel
Böhm, Michael
Mahfoud, Felix
Language: English
Title: Circulation
Volume: 150
Issue: 20
Pages: 1599-1611
Publisher/Platform: Wolters Kluwer
Year of Publication: 2024
Free key words: arterial hypertension
meta-analysis
renal denervation
DDC notations: 610 Medicine and health
Publikation type: Journal Article
Abstract: BACKGROUND: Several sham-controlled trials have investigated the efficacy and safety of catheter-based renal denervation (RDN) with mixed outcomes. We aimed to perform a comprehensive meta-analysis of all randomized, sham-controlled trials investigating RDN with first- and second-generation devices in hypertension. METHODS: We searched MEDLINE and the Cochrane Library for eligible trials. Outcomes included both efficacy (24-hour and office systolic [SBP] and diastolic blood pressure [DBP]) and safety (all-cause death, vascular complication, renal artery stenosis >70%, hypertensive crisis) of RDN. We performed a study-level, pairwise, random-effects meta-analysis of the summary data. RESULTS: Ten trials comprising 2478 patients with hypertension while being either off or on treatment were included. Compared with sham, RDN reduced 24-hour and office systolic blood pressure by 4.4 mmHg (95% CI, 2.7 to 6.1; P<0.00001) and 6.6 mmHg (95% CI, 3.6 to 9.7; P<0.0001), respectively. The 24-hour and office diastolic blood pressure paralleled these findings (–2.6 mmHg [95% CI, –3.6 to –1.5]; P<0.00001; –3.5 mmHg [95% CI, –5.4 to –1.6]; P=0.0003). There was no difference in 24-hour and office systolic blood pressure reduction between trials with and without concomitant antihypertensive medication (P for interaction, 0.62 and 0.73, respectively). There was no relevant difference in vascular complications (odds ratio, 1.69 [95% CI, 0.57 to 5.0]; P=0.34), renal artery stenosis (odds ratio, 1.50 [95% CI, 0.06 to 36.97]; P=0.80), hypertensive crisis (odds ratio, 0.65 [95% CI, 0.30 to 1.38]; P=0.26), and all-cause death (odds ratio, 1.76 [95% CI, 0.34 to 9.20]; P=0.50) between RDN and sham groups. Change of renal function based on estimated glomerular filtration rate was comparable between groups (P for interaction, 0.84). There was significant heterogeneity between trials. CONCLUSIONS: RDN safely reduces ambulatory and office systolic blood pressure/diastolic blood pressure versus a sham procedure in the presence and absence of antihypertensive medications.
DOI of the first publication: 10.1161/CIRCULATIONAHA.124.069709
URL of the first publication: https://doi.org/10.1161/CIRCULATIONAHA.124.069709
Link to this record: urn:nbn:de:bsz:291--ds-439889
hdl:20.500.11880/39360
http://dx.doi.org/10.22028/D291-43988
ISSN: 1524-4539
0009-7322
Date of registration: 13-Jan-2025
Description of the related object: Supplemental Material
Related object: https://www.ahajournals.org/doi/suppl/10.1161/CIRCULATIONAHA.124.069709/suppl_file/circ_circulationaha-2024-069709_supp1.pdf
Faculty: M - Medizinische Fakultät
Department: M - Innere Medizin
Professorship: M - Prof. Dr. Michael Böhm
Collections:SciDok - Der Wissenschaftsserver der Universität des Saarlandes

Files for this record:
There are no files associated with this item.


Items in SciDok are protected by copyright, with all rights reserved, unless otherwise indicated.